Skip to main content
OpenTrials
Completed

NCT Number: NCT00643422

Reproducibility of Cirrus Optical Coherence Tomography Measurements

In this study the reproducibility of optical coherence tomography measurements should be evaluated.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Rudolf Foundation Clinic

Vienna, 1030, Austria

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years of age or older
  • best corrected visual acuity of at least 20/25
  • clear optical media

Exclusion criteria

  • any kind of retinal pathology
  • any kind of opacity of optical media
  • any kind of intraocular surgery
  • spherical refraction of more than 5 diopters
  • cylindrical refraction of more than 3 diopters
  • amblyopia

Treatment and study plan

Cirrus™ HD-OCT, Carl Zeiss Meditec AG

Device

the retinal thickness and volume is determined on two different days with the Cirrus™ HD-OCT.

Primary outcomes

  1. retinal thickness

    Time frame: two

Secondary outcomes

  1. retinal volume

    Time frame: two

Sponsors and collaborators

Lead sponsor

The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery

Other

Registry information

Official study title

Reproducibility of Retinal Thickness and Volume Measurements Determined With the Cirrus Spectral Domain OCT

Important dates

First posted
Mar 26, 2008
Registry last updated
Jul 22, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.